Early Diagnosis, Pathogenesis and Progression of Open Angle Glaucoma

NCT ID: NCT00494923

Last Updated: 2013-12-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

2500 participants

Study Classification

OBSERVATIONAL

Study Start Date

1999-01-31

Study Completion Date

2020-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Erlangen Glaucoma Registry is a clinical registry for cross sectional and longitudinal observation of patients with open angle glaucoma (OAG) or glaucoma suspect, founded in 1991. The primary aim is the evaluation of diagnostic and prognostic validity of morphometrical, sensory and hemodynamical diagnostic procedures. No therapeutic studies are performed.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Purpose: Detection of onset and progression of structural and functional damage due to glaucoma. Determination of rate and amount of progressive change due to glaucoma. Characterisation of the relationship between structural and functional change over time. Evaluation of predictive factors for the development and progression of glaucoma.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Primary Open Angle Glaucoma Secondary Open Angle Glaucoma Ocular Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Open anterior chamber angle
* Best corrected visual acuity 0.7 or better
* Age between 18 and 65 years

Exclusion Criteria

* Any eye disease other than glaucoma
* Systemic diseases with potentially ocular involvement (e.g., diabetes mellitus)
* Myopic or hyperopic refractive error exceeding 8.0 diopters
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

German Research Foundation

OTHER

Sponsor Role collaborator

University of Erlangen-Nürnberg Medical School

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Anselm G Juenemann, Prof.

Role: STUDY_CHAIR

University Erlangen-Nuremberg

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Eye Hospital

Erlangen, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Anselm G Juenemann, Prof.

Role: CONTACT

Phone: **49-9131-8533001

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Robert Laemmer, MD

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Wessel JM, Horn FK, Tornow RP, Schmid M, Mardin CY, Kruse FE, Juenemann AG, Laemmer R. Longitudinal analysis of progression in glaucoma using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2013 May 1;54(5):3613-20. doi: 10.1167/iovs.12-9786.

Reference Type RESULT
PMID: 23633657 (View on PubMed)

Hoesl LM, Tornow RP, Schrems WA, Horn FK, Mardin CY, Kruse FE, Juenemann AG, Laemmer R. Glaucoma diagnostic performance of GDxVCC and spectralis OCT on eyes with atypical retardation pattern. J Glaucoma. 2013 Apr-May;22(4):317-24. doi: 10.1097/IJG.0b013e318237c8c5.

Reference Type RESULT
PMID: 22027931 (View on PubMed)

Schrems WA, Laemmer R, Hoesl LM, Horn FK, Mardin CY, Kruse FE, Tornow RP. Influence of atypical retardation pattern on the peripapillary retinal nerve fibre distribution assessed by scanning laser polarimetry and optical coherence tomography. Br J Ophthalmol. 2011 Oct;95(10):1437-41. doi: 10.1136/bjo.2010.190074. Epub 2011 Jan 17.

Reference Type RESULT
PMID: 21242583 (View on PubMed)

Hoesl LM, Mardin CY, Horn FK, Juenemann AG, Laemmer R. Influence of glaucomatous damage and optic disc size on glaucoma detection by scanning laser tomography. J Glaucoma. 2009 Jun-Jul;18(5):385-9. doi: 10.1097/IJG.0b013e3181845ffd.

Reference Type RESULT
PMID: 19525729 (View on PubMed)

Schrems WA, Mardin CY, Horn FK, Juenemann AG, Laemmer R. Comparison of scanning laser polarimetry and optical coherence tomography in quantitative retinal nerve fiber assessment. J Glaucoma. 2010 Feb;19(2):83-94. doi: 10.1097/IJG.0b013e3181a2fc0e.

Reference Type RESULT
PMID: 19373100 (View on PubMed)

Horn FK, Mardin CY, Laemmer R, Baleanu D, Juenemann AM, Kruse FE, Tornow RP. Correlation between local glaucomatous visual field defects and loss of nerve fiber layer thickness measured with polarimetry and spectral domain OCT. Invest Ophthalmol Vis Sci. 2009 May;50(5):1971-7. doi: 10.1167/iovs.08-2405. Epub 2009 Jan 17.

Reference Type RESULT
PMID: 19151389 (View on PubMed)

Laemmer R, Schroeder S, Martus P, Viestenz A, Mardin CY. Quantification of neuroretinal rim loss using digital planimetry in long-term follow-up of normals and patients with ocular hypertension. J Glaucoma. 2007 Aug;16(5):430-6. doi: 10.1097/IJG.0b013e31804a5e80.

Reference Type RESULT
PMID: 17700284 (View on PubMed)

Laemmer R, Horn FK, Viestenz A, Juenemann AG, Mardin CY. Influence of optic disc size on parameters of retinal nerve fiber analysis with laser scanning polarimetry. Graefes Arch Clin Exp Ophthalmol. 2006 May;244(5):603-8. doi: 10.1007/s00417-005-0125-1. Epub 2005 Sep 21.

Reference Type RESULT
PMID: 16175374 (View on PubMed)

Tornow RP, Schrems WA, Bendschneider D, Horn FK, Mayer M, Mardin CY, Lammer R. Atypical retardation patterns in scanning laser polarimetry are associated with low peripapillary choroidal thickness. Invest Ophthalmol Vis Sci. 2011 Sep 29;52(10):7523-8. doi: 10.1167/iovs.11-7557.

Reference Type RESULT
PMID: 21862653 (View on PubMed)

Horn FK, Lammer R, Mardin CY, Junemann AG, Michelson G, Lausen B, Adler W. Combined evaluation of frequency doubling technology perimetry and scanning laser ophthalmoscopy for glaucoma detection using automated classification. J Glaucoma. 2012 Jan;21(1):27-34. doi: 10.1097/IJG.0b013e3182027766.

Reference Type RESULT
PMID: 21173705 (View on PubMed)

Pasutto F, Krumbiegel M, Mardin CY, Paoli D, Lammer R, Weber BH, Kruse FE, Schlotzer-Schrehardt U, Reis A. Association of LOXL1 common sequence variants in German and Italian patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1459-63. doi: 10.1167/iovs.07-1449.

Reference Type RESULT
PMID: 18385063 (View on PubMed)

Crux K, Huchzermeyer C, Kremers J, Horn FK. Objective detection of visual field defects with multifrequency VEPs. Doc Ophthalmol. 2024 Feb;148(1):15-24. doi: 10.1007/s10633-023-09949-4. Epub 2023 Sep 26.

Reference Type DERIVED
PMID: 37749441 (View on PubMed)

Dussan Molinos L, Huchzermeyer C, Lammer R, Kremers J, Horn FK. Blue-Yellow VEP with Projector-Stimulation in Glaucoma. Graefes Arch Clin Exp Ophthalmol. 2022 Apr;260(4):1171-1181. doi: 10.1007/s00417-021-05473-w. Epub 2021 Nov 25.

Reference Type DERIVED
PMID: 34821990 (View on PubMed)

Thiermeier N, Lammer R, Mardin C, Hohberger B. Erlanger Glaucoma Registry: Effect of a Long-Term Therapy with Statins and Acetyl Salicylic Acid on Glaucoma Conversion and Progression. Biology (Basel). 2021 Jun 16;10(6):538. doi: 10.3390/biology10060538.

Reference Type DERIVED
PMID: 34208432 (View on PubMed)

Denkel L, Hohberger B, Lammer R. Influence of Mitomycin C on the Therapeutic Success of Stand-Alone Xen45 Gel Stents and Its Combination with Cataract Surgery in Open-Angle Glaucoma Patients. Klin Monbl Augenheilkd. 2021 Aug;238(8):861-867. doi: 10.1055/a-1384-1020. Epub 2021 May 17.

Reference Type DERIVED
PMID: 34000747 (View on PubMed)

Hohberger B, Lucio M, Schlick S, Wollborn A, Hosari S, Mardin C. OCT-angiography: Regional reduced macula microcirculation in ocular hypertensive and pre-perimetric glaucoma patients. PLoS One. 2021 Feb 11;16(2):e0246469. doi: 10.1371/journal.pone.0246469. eCollection 2021.

Reference Type DERIVED
PMID: 33571215 (View on PubMed)

Tornow RP, Kolar R, Odstrcilik J, Labounkova I, Horn F. Imaging video plethysmography shows reduced signal amplitude in glaucoma patients in the area of the microvascular tissue of the optic nerve head. Graefes Arch Clin Exp Ophthalmol. 2021 Feb;259(2):483-494. doi: 10.1007/s00417-020-04934-y. Epub 2020 Sep 22.

Reference Type DERIVED
PMID: 32960321 (View on PubMed)

Hohberger B, Kunze R, Wallukat G, Kara K, Mardin CY, Lammer R, Schlotzer-Schrehardt U, Hosari S, Horn F, Munoz L, Herrmann M. Autoantibodies Activating the beta2-Adrenergic Receptor Characterize Patients With Primary and Secondary Glaucoma. Front Immunol. 2019 Oct 1;10:2112. doi: 10.3389/fimmu.2019.02112. eCollection 2019.

Reference Type DERIVED
PMID: 31632387 (View on PubMed)

Edlinger FSM, Schrems-Hoesl LM, Mardin CY, Laemmer R, Kruse FE, Schrems WA. Structural changes of macular inner retinal layers in early normal-tension and high-tension glaucoma by spectral-domain optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2018 Jul;256(7):1245-1256. doi: 10.1007/s00417-018-3944-6. Epub 2018 Mar 9.

Reference Type DERIVED
PMID: 29523993 (View on PubMed)

Junemann A, Hohberger B, Rech J, Sheriff A, Fu Q, Schlotzer-Schrehardt U, Voll RE, Bartel S, Kalbacher H, Hoebeke J, Rejdak R, Horn F, Wallukat G, Kunze R, Herrmann M. Agonistic Autoantibodies to the beta2-Adrenergic Receptor Involved in the Pathogenesis of Open-Angle Glaucoma. Front Immunol. 2018 Feb 12;9:145. doi: 10.3389/fimmu.2018.00145. eCollection 2018.

Reference Type DERIVED
PMID: 29483909 (View on PubMed)

Schrems-Hoesl LM, Schrems WA, Laemmer R, Kruse FE, Mardin CY. Precision of Optic Nerve Head and Retinal Nerve Fiber Layer Parameter Measurements by Spectral-domain Optical Coherence Tomography. J Glaucoma. 2018 May;27(5):407-414. doi: 10.1097/IJG.0000000000000875.

Reference Type DERIVED
PMID: 29329141 (View on PubMed)

Diekmann T, Schrems-Hoesl LM, Mardin CY, Laemmer R, Horn FK, Kruse FE, Schrems WA. Predictive Factors for Visual Field Conversion: Comparison of Scanning Laser Polarimetry and Optical Coherence Tomography. J Glaucoma. 2018 Feb;27(2):157-163. doi: 10.1097/IJG.0000000000000833.

Reference Type DERIVED
PMID: 29194206 (View on PubMed)

Gmeiner JM, Schrems WA, Mardin CY, Laemmer R, Kruse FE, Schrems-Hoesl LM. Comparison of Bruch's Membrane Opening Minimum Rim Width and Peripapillary Retinal Nerve Fiber Layer Thickness in Early Glaucoma Assessment. Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT575-84. doi: 10.1167/iovs.15-18906.

Reference Type DERIVED
PMID: 27547890 (View on PubMed)

Schrems-Hoesl LM, Schrems WA, Laemmer R, Horn FK, Juenemann AG, Kruse FE, Mardin CY. Confocal Laser Scanning Tomography to Predict Visual Field Conversion in Patients With Ocular Hypertension and Early Glaucoma. J Glaucoma. 2016 Apr;25(4):371-6. doi: 10.1097/IJG.0000000000000171.

Reference Type DERIVED
PMID: 25304282 (View on PubMed)

La Mancusa A, Horn FK, Kremers J, Huchzermeyer C, Rudolph M, Junemann A. Pattern electroretinograms during the cold pressor test in normals and glaucoma patients. Invest Ophthalmol Vis Sci. 2014 Apr 7;55(4):2173-9. doi: 10.1167/iovs.13-13392.

Reference Type DERIVED
PMID: 24576876 (View on PubMed)

Horn FK, Tornow RP, Junemann AG, Laemmer R, Kremers J. Perimetric measurements with flicker-defined form stimulation in comparison with conventional perimetry and retinal nerve fiber measurements. Invest Ophthalmol Vis Sci. 2014 Apr 11;55(4):2317-23. doi: 10.1167/iovs.13-12469.

Reference Type DERIVED
PMID: 24355823 (View on PubMed)

Horn FK, Kaltwasser C, Junemann AG, Kremers J, Tornow RP. Objective perimetry using a four-channel multifocal VEP system: correlation with conventional perimetry and thickness of the retinal nerve fibre layer. Br J Ophthalmol. 2012 Apr;96(4):554-9. doi: 10.1136/bjophthalmol-2011-300844. Epub 2011 Nov 24.

Reference Type DERIVED
PMID: 22116959 (View on PubMed)

Barboni MT, Pangeni G, Ventura DF, Horn F, Kremers J. Heterochromatic flicker electroretinograms reflecting luminance and cone opponent activity in glaucoma patients. Invest Ophthalmol Vis Sci. 2011 Aug 29;52(9):6757-65. doi: 10.1167/iovs.11-7538.

Reference Type DERIVED
PMID: 21778269 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DFG-SFB539-R

Identifier Type: -

Identifier Source: org_study_id